Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (161-170 of 428) with videos related to

Pageof 43
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|February 13, 2003
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-onesAngela Rao, Anna Carbone, Alba Chimirri, et al.
Antiviral Research|April 13, 2007
Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycleEls Keyaerts, Leen Vijgen, Christophe Pannecouque, et al.
ACS Infectious Diseases|October 11, 2019
Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic ProfilesSheng Han, Yali Sang, Yan Wu, et al.
European Journal of Medicinal Chemistry|November 19, 2019
Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitorsSheng Han, Yali Sang, Yan Wu, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 7, 2002
Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazolesMarina Kritsanida, Anastasia Mouroutsou, Panagiotis Marakos, et al.
Viruses|December 28, 2021
Deciphering the Role of Extracellular Vesicles Derived from ZIKV-Infected hcMEC/D3 Cells on the Blood-Brain Barrier SystemAntonios Fikatas, Jonas Dehairs, Sam Noppen, et al.
European Journal of Medicinal Chemistry|April 29, 2014
Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approachXiao Li, Wenmin Chen, Ye Tian, et al.
Chemical & Pharmaceutical Bulletin|August 5, 2005
Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analoguesGuang-Fu Sun, Xu-Xiang Chen, Fen-Er Chen, et al.
AIDS (London, England)|December 4, 2004
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel, et al.
Bioorganic & Medicinal Chemistry|June 21, 2011
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsJing Zhang, Peng Zhan, Jingde Wu, et al.
Pageof 43

Showing results (161-170 of 428) with videos related to

Sort By:
Pageof 43
Farmaco (Societa Chimica Italiana : 1989)|February 13, 2003
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-onesAngela Rao, Anna Carbone, Alba Chimirri, et al.
Antiviral Research|April 13, 2007
Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycleEls Keyaerts, Leen Vijgen, Christophe Pannecouque, et al.
ACS Infectious Diseases|October 11, 2019
Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic ProfilesSheng Han, Yali Sang, Yan Wu, et al.
European Journal of Medicinal Chemistry|November 19, 2019
Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitorsSheng Han, Yali Sang, Yan Wu, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 7, 2002
Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazolesMarina Kritsanida, Anastasia Mouroutsou, Panagiotis Marakos, et al.
Viruses|December 28, 2021
Deciphering the Role of Extracellular Vesicles Derived from ZIKV-Infected hcMEC/D3 Cells on the Blood-Brain Barrier SystemAntonios Fikatas, Jonas Dehairs, Sam Noppen, et al.
European Journal of Medicinal Chemistry|April 29, 2014
Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approachXiao Li, Wenmin Chen, Ye Tian, et al.
Chemical & Pharmaceutical Bulletin|August 5, 2005
Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analoguesGuang-Fu Sun, Xu-Xiang Chen, Fen-Er Chen, et al.
AIDS (London, England)|December 4, 2004
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel, et al.
Bioorganic & Medicinal Chemistry|June 21, 2011
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsJing Zhang, Peng Zhan, Jingde Wu, et al.
Pageof 43